Chenghui Medical applied for listing on the new three-year net profit of 810,000 yuan

Chenghui Medical

On October 31, Guangdong Chenghui Medical Technology Co., Ltd. (hereinafter referred to as Chenghui Medical ) has officially applied for the listing of the New Third Board. The listing information disclosed by the National Stock Transfer System shows that Zhang Xuhui, the chairman of Chenghui Medical, directly holds the shares. 68.47%, the actual controller.

According to the announcement, the operating income of Chenghui Medical in 2014, 2015 and January-June 2016 was 18.91 million yuan, 21,352,600 yuan and 152.96 million yuan respectively; the net profit was 52,300 yuan, 21,900 yuan and 8.109 million yuan respectively.

According to the data of the New Three Board Research Institute, the main business of Chenghui Medical is the distribution of medical equipment and consumables. In addition, Chenghui Medical is also engaged in research and development, promotion and sales of some medical equipment products such as oxygen generators and disinfectors.

Molecular Diagnostic PCR Reagent for Pathogens

Molecular diagnosis like RT-PCR assays for the identifification of pathogens associated with a variety of infectious diseases such as: respiratory infections, gastrointestinal infection, sexually transmitted infections, bacterial resistance and vetor-borne diseases.

PCR,Molecular diagnostic ,PCR Reagent,,Respiratory Infections,Gastrointestinal Infection,STD Infection,Vetor-borne Diseases

Shenzhen Uni-medica Technology Co.,Ltd , https://www.unimed-global.com

Posted on